Doxorubicin and doxorubicinol: intra-and inter-individual variations of pharmacokinetic parameters

Cancer Chemotherapy and Pharmacology

Volumn 27, Issue 3, 1990, Pages 219-225

  Jacquet, Jeanne Marie ^a   Bressolle, Françoise ^a   Galtier, Marc ^b   Bourrier, Magali ^a   Donadio, Daniel ^c   Jourdan, Jacques ^a   Rossi, Jean François ^d  

^a UNIV MONTPELLIER   (France)

^b CHRU Nîmes et UM

^c LAPEYRONIE HOSPITAL   (France)

^d CENTRE VAL D AURELLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; DOXORUBICINOL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DRUG HALF LIFE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PHARMACOKINETICS; PRIORITY JOURNAL; VARIANCE;

ADULT; AGED; DOXORUBICIN; FEMALE; HUMAN; INDIVIDUALITY; MALE; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T;

EID: 0025642898     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/BF00685716     Document Type: Article

References (27)

1. Plasma pharmacokinetics of Adriamycin and its metabolites in humans with normal hepatic and renal function
2. The human plasma pharmacokinetics of doxorubicin: comparison of bolus and infusional administration
3. Prediction of Adriamycin disposition in cancer patients using a physiologic, pharmacokinetic model
4. Clinical pharmacokinetics of Adriamycin in hepatoma patients with cirrhosis
5. Die Pharmacokinetik von Adriamycin und Adriamycin-Metaboliten
6. Intrahepatic and intravenous administration of Adriamycin: a comparative pharmacokinetic study in patients with malignant liver tumours
7. Pharmacokinetic study of IV infusions of Adriamycin
8. Comparative pharmacokinetic study of Adriamycin and 4′-epi-Adriamycin after their simultaneous intravenous administration
9. Pharmacokinetic of doxorubicin in man: dose and schedule dependence
10. Adriamycin pharmacokinetics in children
11. Time dependency of Adriamycin and Adriamycinol kinetics
12. PHARM: an interactive graphic program for individual and population pharmacokinetic parameter estimation
13. Plasma pharmacokinetics of Adriamycin and Adriamycinol: implications for the design of in vitro experiments and treatment protocols
14. A limited sampling procedure for estimation of Adriamycin pharmacokinetics in cancer patients
15. Distribution of ADM in cancer patients, tissue uptakes, plasma concentrations after intravenous and hepatic intraarterial administration
16. Pharmacokinetics and metabolism of epidoxorubicin and doxorubicin in humans
17. The kinetics of anthracyclines in human plasma and tissues: daunorubicin, doxorubicin and 4 epi-doxorubicin
18. Klinische pharmacokinetiek van adriamycine
19. Extraction of anthracyclines from biological fluids for HPLC evaluation
20. Pharmacokinetics of Adriamycin in patients with breast cancer: correlation between pharmacokinetic parameters and clinical short-term response
21. Etude pharmacocinétique de la doxorubicine dans le traitement des lymphomes malins non hodgkiniens
22. Comparative pharmacokinetics and metabolism of doxorubicin and epirubicin in patients with metastatic breast cancer
23. Pharmacokinetics of doxorubicin in sarcoma patients
24. Doxorubicin clearance in the obese
25. Plasma and cellular Adriamycin concentrations in patients with myeloma treated with ninety-six-hour continuous infusion
26. Cellular and plasma Adriamycin concentrations in long-term infusion therapy of leukemia patiens
27. Clinical pharmacokinetics of doxorubicin